APRIL 2017

NSF PHASE II GRANT AWARDED

Phase Diagnostics is proud to receive the $750k Phase II grant award from the National Science Foundation. The funding will enable us to further develop our rapid point-of-care test for Chlamydia trachomatis towards commercialization.

MARCH 2017

NIH PHASE I/II FAST TRACK GRANT AWARDED

Phase Diagnostics is proud to receive the $1.15 million Phase I/II Fast Track grant award from the National Institutes of Health. The funding will enable us to further develop our rapid point-of-care test for Chlamydia trachomatis towards commercialization.

NOVEMBER 2016

BILL AND MELINDA GATES FOUNDATION GRANT AWARDED

Phase Diagnostics is very excited to announce our Bill and Melinda Gates Foundation Grand Challenges award. The $100k funding will allow us to apply our technology in developing a saliva-based rapid point-of-care test for malaria that is fully integrated and does not require equipment, power or trained technicians.

NOVEMBER 2015

NSF PHASE I GRANT AWARDED

Phase Diagnostics is proud to receive the $150k Phase I grant award from the National Science Foundation. The funding will allow us to investigate the development of a novel, one step rapid point-of-care (POC) diagnostic for Chlamydia trachomatis (CT) infection.